Literature DB >> 15297233

[Clinico-biological evaluation of malnutrition].

K Bach-Ngohou1, A Bettembourg, D Le Carrer, D Masson, M Denis.   

Abstract

Malnutrition is frequently observed at hospital, concerning 30 to 50% of hospitalised patients. Increased length of stay and cost of care has made of this problem a major economic stake. Indeed, malnutrition diagnosis and prevention has become, since 2001, one of major french government's priority. Malnutrition results from unbalanced nutritional requirement and in-take. It associates both weight, proteic and functional loss. Its diagnosis and evaluation of its gravity are first clinical and need body mass index determination. For biological diagnosis, nutritional markers have to be very sensitive to nutritional state. Nutritional profile can be made, associating two nutritional markers (albumin and transthyretin) and one inflammation protein (alpha 1-acid-glycoprotein). Various clinical, biological or clinico-biological indexes can also be calculated. Altogether, both indexes and nutrition profile are excellent tools for (1) diagnosis and classification of malnutrition state, moderate or severe, (2) prognostic and (3) evaluation of nutritional supplementation efficiency. Copyright John Libbey Eurotext 2003.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15297233

Source DB:  PubMed          Journal:  Ann Biol Clin (Paris)        ISSN: 0003-3898            Impact factor:   0.459


  1 in total

1.  The Impact of Macro-and Micronutrients on Predicting Outcomes of Critically Ill Patients Requiring Continuous Renal Replacement Therapy.

Authors:  Kittrawee Kritmetapak; Sadudee Peerapornratana; Nattachai Srisawat; Nicha Somlaw; Narisorn Lakananurak; Thasinas Dissayabutra; Chayanat Phonork; Asada Leelahavanichkul; Khajohn Tiranathanagul; Paweena Susantithapong; Passisd Loaveeravat; Nattachai Suwachittanont; Thaksa-On Wirotwan; Kearkiat Praditpornsilpa; Kriang Tungsanga; Somchai Eiam-Ong; Piyawan Kittiskulnam
Journal:  PLoS One       Date:  2016-06-28       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.